CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Anesthetic Conserving Device (AnaConDa )device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01339013
NCT01339013N/ACompleted

Dead Space Effect of an Anaesthesia Gas Reflector (AnaConDa)

Region Skane·interventional·Posted Apr 20, 2011·Updated Sep 25, 2014

In Brief

A clinical study evaluating Anesthetic Conserving Device (AnaConDa ) for Anesthetic Ventilatory Requirements. Completed, enrolled 6 participants across 1 site.

Detailed Summary

The anesthesia gas reflector (AnaConDa) is built on the adsorptive capacity of active carbon which also adsorbs carbon dioxide in exhaled air. Rebreathing of carbon dioxide thus occurs and must be compensated for by increased ventilation. This study aims at determining how much compensation must be given, based on the hypothesis that rebreathing depends on carbon dioxide level in blood and exhaled air.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 20, 2011
Enrollment StartApr 1, 2011
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.2 years ago

Interventions

Anesthetic Conserving Device (AnaConDa )device

Standard HME was replaced by AnaConDa. AnaConDa has charcoal filter, HME does not.